logo
episode-header-image
Sep 2020
46m 19s

Eli Lilly CEO, Coca Cola CEO & Albertson...

CNBC
About this episode

The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's progress with cardiology, migraine, and cancer drugs as well as a COVID-19 treatment. Then, Cramer's got the exclusive with the CEO of Coca-Cola, James Quincey, to break down demand brought on by the pandemic. Plus, Albertsons Companies CEO Vivek Sankaran joins Cramer to talk about the company’s recent IPO.

Up next
Yesterday
Mad Money w/ Jim Cramer 7/9/25
Listen to Jim Cramer’s personal guide through the confusing jungle of Wall Street investing, navigating through opportunities and pitfalls with one goal in mind - to help you make money.Mad Money Disclaimer 
44m 7s
Jul 8
Mad Money w/ Jim Cramer 7/8/25
Listen to Jim Cramer’s personal guide through the confusing jungle of Wall Street investing, navigating through opportunities and pitfalls with one goal in mind - to help you make money.Mad Money Disclaimer 
44m 2s
Jul 7
Mad Money w/ Jim Cramer 7/7/25
Listen to Jim Cramer’s personal guide through the confusing jungle of Wall Street investing, navigating through opportunities and pitfalls with one goal in mind - to help you make money.Mad Money Disclaimer 
38m 18s
Recommended Episodes
Jan 2022
Markets Rally, Tesla and the Earnings Parade, Southwest’s Outgoing CEO on Profitability and Omicron, ServiceNow CEO on Stock Surge, and Netflix and “Bill.”
One day after the Fed weighed on markets by signaling a mid-March rate hike, Carl Quintanilla, Jim Cramer and David Faber stayed on top of a rally sparked in part by stronger-than-expected fourth quarter GDP, showing 6.9% growth on an annualized basis. Cramer explained how invest ... Show More
44m 15s
Aug 2021
The Chinese Stock Rally and the Cathie Wood Effect, Mandates and the Reopening Trade After Full Approval of Pfizer's COVID Vaccine, Boeing Faces New Scrutiny, Tim Cook's Decade as CEO of Apple, and t
Carl Quintanilla, Jim Cramer and David Faber explored the reasons behind a big rally in shares of China-based companies. One of the catalysts: Cathie Wood's Ark Invest buying almost 165,000 shares of JD.com. The reopening trade very much in focus one day after the FDA fully appro ... Show More
44m 6s
Jul 2021
Stocks Erase Losses from Monday's Sell-off, Dow Components Join the Earnings Parade, Netflix's Subscriber Growth Slowdown, United Sees Profitablilty Ahead, J&J's COVID Vaccine Under Scrutiny, and Chip
Jim Cramer and David Faber took an in-depth look at a busy day for the markets with a slew of earnings reports in the mix -- as stocks recouped all of their losses from Monday's sell-off. Dow components Coca-Cola, Johnson & Johnson and Verizon all beating analyst expectations wit ... Show More
43m 12s
Sep 2021
Tech Stock Sell-off, Carl at the Code Conference, Countdown to Powell and Yellen on the Hill, Ford's $11.4B bet on EVs, and the CEO of Robinhood Fires Back At Critics
Jim Cramer and David Faber led off with a rough start for the markets: Tech stocks in sell-off mode as the 10-year note yield hits a fresh three-month high. Jim and David focused on the mega-cap tech names and whether now is the time to buy. Speaking of tech: At the Code Conferen ... Show More
43m 20s
Nov 2021
Moderna Cuts Vaccine Outlook, Qualcomm Shares Surge, Kyndryl Begins Trading
Carl Quintanilla, Jim Cramer and David Faber began the show with a look at Moderna shares sliding, after cutting its Covid-19 vaccine sales forecast. The company is now expecting to deliver between 700-800 million does this year, down from previous expectations of between 800 mil ... Show More
46m 12s
Dec 2021
Inflation Surges, Fed "In Trouble," Meme Stock Sadness, Tesla Below $1T Valuation As Musk Sells More Shares, and Pfizer's Antiviral COVID 19-Pill vs. Omicron.
Jim Cramer and David Faber led off the show with market reaction to the latest inflation data: The Producer Price Index shows wholesale prices surged in November, up 9.6% year-over-year. This as the Fed kicks off its final two-day policy meeting of 2021. Cramer explained why he b ... Show More
43m 20s
Dec 2021
After the Rally: Pfizer's COVID Booster vs. Omicron, Apple's Record Run, The EV Battle Intensifies and Stitch Fix Plummets
The morning after the best day for both the S&P 500 and Nasdaq since March, Carl Quintanilla, Jim Cramer and David Faber led off the show with news out of Pfizer and BioNTech: Data shows their COVID-19 vaccine neutralized the omicron variant with three shots. The anchors discusse ... Show More
43m 51s
Nov 2020
COVID-19 Worries Pressure Stocks, Presidential Transition: The Business Community Speaks Out, Exclusive With Media Mogul John Malone, And GoodRx Co-CEO Reacts To Amazon Pharmacy
Carl Quintanilla, Jim Cramer and David Faber discussed the Dow and S&P 500 extending Wednesday's losses on worries about COVID-19, with deaths surpassing 250,000 in the U.S. -- and therecent surge in cases resulting in lockdowns. The anchors also took a closer look at a push by b ... Show More
42m 38s
Nov 2021
Job Creation Roars Back, Labor Secretary Marty Walsh, Pfizer’s Covid-19 Pill, Peloton Gets Smacked
Carl Quintanilla and Jim Cramer begin the morning discussing Pfizer’s announcement that its experimental COVID-19 pill reduces the risk of death and hospitalization by 89%. Shares of Pfizer surging on the news. Plus, job creation roaring back in October as payrolls rose by 531,00 ... Show More
42m 52s
May 2021
The Reopening Trade: Uber's Revenue Miss, Vaccine Makers Tumble and Peloton After the Sell-off. Earnings Winners and Losers from ViacomCBS and PayPal to Etsy ... Plus "Reunited and It Feels So Good!"
Carl Quintanilla, Jim Cramer and David Faber took a wide-ranging look at the reopening trade: Uber shares under pressure after the company reported a revenue miss, vaccine makers such as Pfizer, BioNTech and Moderna saw their shares take a hit after the Biden Administration annou ... Show More
43m 54s